Oxybutynin Extended Release for the Management of Overactive Bladder: A Clinical Review

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s3370
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Transdermal Oxybutynin: What Role in the Management of Overactive Bladder?

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2010English

Update on Tolterodine Extended-Release for Treatment of Overactive Bladder

Open Access Journal of Urology
2010English

Development of Oxybutynin Chloride Topical Gel for Overactive Bladder

Research and Reports in Urology
Urology
2011English

Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain

Journal of Health Economics and Outcomes Research
2018English

Management of Overactive Bladder

2018English

Sacral Neuromodulation for Treatment of Overactive Bladder: A Review

Revista de Medicina
2018English

PUK10 Cost-Effectiveness Analysis of Solifenacin Versus Oxybutynin Immediate-Release in the Treatment of Patients With Overactive Bladder in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Acupuncture for Adults With Overactive Bladder: A Systematic Review Protocol

BMJ Open
Medicine
2015English

Botulinum Toxin a for the Treatment of Overactive Bladder

Toxins
MutagenesisToxicologyHealth
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy